Literature DB >> 778271

An immuno-enzymatic assay of cortisol using E. coli beta-galactosidase as label.

S Comoglio, F Celada.   

Abstract

An enzyme-assay of cortisol was established by using E. coli beta-galactosidase as a marker. The number of cortisol residues per molecule of enzyme and the method of separation of free from antibody-bound enzyme proved to be critical factors for the assessment of the assay. A sensitivity ranging from 100 to 150 pg of cortisol per tube has been achieved. A comparsion with other methods, i.e. competitive protein binding assay, radioimmunoassay and fluorimetry, is reported.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 778271     DOI: 10.1016/0022-1759(76)90167-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

Review 1.  Enzyme immunoassays with special reference to ELISA techniques.

Authors:  A Voller; A Bartlett; D E Bidwell
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

2.  Amplification immunoassay for the determination of hepatitis B surface antigen.

Authors:  A Seki; E Tamiya; I Karube
Journal:  Appl Biochem Biotechnol       Date:  1991-03       Impact factor: 2.926

3.  A novel method in enzyme immunoassay: maleimide derivative of hapten for enzyme coupling.

Authors:  A Castro; N Monji
Journal:  Experientia       Date:  1979-04-15

4.  Synthesis of maleimide derivative of cortisol for enzyme coupling is cortisol enzyme immunoassay.

Authors:  N Monji; A Castro
Journal:  Experientia       Date:  1980-03-15

5.  Quantification of digoxin by enzyme immunoassay: synthesis of a maleimide derivative of digoxigenin succinate for enzyme coupling.

Authors:  N Monji; H Ali; A Castro
Journal:  Experientia       Date:  1980-10-15

Review 6.  Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites.

Authors:  Seiichi Sakamoto; Waraporn Putalun; Sornkanok Vimolmangkang; Waranyoo Phoolcharoen; Yukihiro Shoyama; Hiroyuki Tanaka; Satoshi Morimoto
Journal:  J Nat Med       Date:  2017-11-21       Impact factor: 2.343

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.